MedTrace Logo

Prospective Placebo-controlled Study of Synochi Scar Spray

NCT05138107 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2022-06-16

No results posted yet for this study

Summary

Randomized, double-blind, placebo controlled, prospective, split-scar study of severe burn victims with autologous skin transplants. 9 months intervention time and 3 months follow-up, photographic scar documentation, self-and observer questionnaires throughout

Conditions

  • Burns Multiple

Interventions

OTHER

Synochi Scar Spray Cosmetic

Application of the cosmetic on each skin graft in a blinded fashion in different sections for a 9 month duration.

OTHER

Synochi Scar Spray Placebo

Application of the placebo on each skin graft in a blinded fashion in different sections for a 9 month duration.

Sponsors & Collaborators

  • LAC+USC Medical Center

    collaborator OTHER

  • Synochi, LLC

    lead INDUSTRY

Principal Investigators

  • Justin Gillenwater, MD · USC School of Medicine

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-01
Primary Completion
2024-05-17
Completion
2025-07-17

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05138107 on ClinicalTrials.gov